BioCatalystWatch
IRLAWorkspace / IRLA / OverviewCompany library
IRulya Therapeutics Inc. logo

IRulya Therapeutics Inc.

IRulya Therapeutics Inc. (QNCX)

Website

Price
Market cap
Next catalystExpected Q4 2026LAM-001 — planned SAPH Phase 2 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

LAM-001

mTOR × FKBP12

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LAM-001

mTOR × FKBP12

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

LAM-001

mTOR × FKBP12

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LAM-001

mTOR × FKBP12

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

AIT-101

PIKfyve

PreINDP1P2P3FilingApproved
AIT-101

PIKfyve

AIT-101

PIKfyve

AIT-101

PIKfyve

AIT-101

PIKfyve

AIT-101

PIKfyve

AIT-102

G/C-rich DNA minor groove

PreINDP1P2P3FilingApproved

History / paused

LAM-001

mTOR × FKBP12

PreINDP1P2P3FilingApproved

Lysine gingipain

PreINDP1P2P3FilingApproved

Lysine gingipain

Lysine gingipain

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

QNCX PR & News

PR & News

QNCX SEC archive